CS
PBMWW

Clear Street’s Psyence Biomedical Warrant PBMWW Stock Holding History

Clear Street’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.68K Hold
257,209
– – ﹤0.01% 1007
2025
Q4 		$4.76K Sell
257,209
-109,356
-30% -$2.76K ﹤0.01% 829
2025
Q3 		$9.24K Buy
366,565
+186,099
+103% +$4.69K ﹤0.01% 688
2025
Q2 		$3.66K Hold
180,466
– – ﹤0.01% 563
2025
Q1 		$3.05K Sell
180,466
-100
-0.1% -$2 ﹤0.01% 448
2024
Q4 		$2.6K Buy
180,566
+140
+0.1% +$2 ﹤0.01% 452
2024
Q3 		$2.27K Buy
180,426
+150
+0.1% +$3 ﹤0.01% 542
2024
Q2 		$1.89K Hold
180,276
– – ﹤0.01% 608
2024
Q1 		$12.6K Buy
+180,276
New +$11.2K ﹤0.01% 371

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return